Importantly, the antibody attenuated tumor growth and metastasis (myeloma, glioma, pancreatic cancer, breast carcinoma, all expressing heparanase enzymatic activity) in both immunocompetent (syngeneic) and immunocompromised mouse models. This evidence concerns the gene HPSE and breast carcinoma.